Search Press releases Keywords From To 1 Jul 2019 Transparency notifications BlackRock, Inc. Read More 27 Jun 2019 UCB and Amgen Provide Regulatory Update on Status of EVENITY® (romosozumab) in the EU Read More 24 Jun 2019 Transparency notifications BlackRock, Inc. Read More 13 Jun 2019 UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis Patients Read More 12 Jun 2019 Transparency notifications BlackRock, Inc. Read More 6 Jun 2019 UCB Showcases the Depth of its Immunology Research and Commitment to Patients at EULAR 2019 Read More Pagination First page Previous page Previous … Page 65 Page 66 Page 67 Page 68 Current page 69 Page 70 Page 71 Page 72 Page 73 Page 69 of 73 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
